Veranex Acquires Leading Pathology and Histology Provider HORUS Scientific

Veranex, the first purpose-built, integrated global service platform for the medtech industry, announced that it has acquired HORUS Scientific, a pathology and histology facility. This acquisition further solidifies Veranex’s global commitment by deepening its end-to-end service capabilities for medtech innovation. HORUS Scientific’s Director, Dr. James ‘Butch’ Stanley, DVM, MS, DACVP, has developed and implemented industry-leading histopathology protocols for over two decades. In addition to product design and engineering, CRO services, and market access and reimbursement consulting, Veranex is an established global leader in preclinical services.

Read the full article: Veranex Acquires Leading Pathology and Histology Provider HORUS Scientific //

Source: https://www.prnewswire.com/news-releases/veranex-acquires-leading-pathology-and-histology-provider-horus-scientific-302132621.html

Leave a Comment

Your email address will not be published.

Scroll to Top